Oxytocin nasal spray for Alcoholism
Study Summary
This trial will study the effects of oxytocin compared to placebo on alcohol and cigarette cravings in smokers with an alcohol use disorder.
- Alcoholism
- Smoking
Eligibility Criteria
Inclusion Criteria
You will be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Awards & Highlights
Trial Design
Find a site
Who is running the clinical trial?
Media Library
Frequently Asked Questions
Has the FDA sanctioned Oxytocin nasal spray for medicinal use?
"As this is an early Phase 1 trial, where safety and efficacy data are limited, Oxytocin nasal spray received a score of 1."
Is enrolment for this research endeavor still accessible to individuals?
"Affirmative. Details on clinicaltrials.gov verify that this trial, first posted in November 2020, is actively recruiting participants. 55 individuals must be sourced from 1 medical site for the study to move forward."
Are geriatric individuals eligible to partake in this experiment?
"Individuals, who are at least 18 years of age and not beyond 55, can sign up for this study."
In what medical contexts is Oxytocin nasal spray regularly employed?
"Oxytocin nasal spray is often employed to help manage excessive bleeding during labour, as well as intense uterine contractions."
How many volunteers are partaking in this clinical experiment?
"Confirmed. Based on the clinicaltrials.gov page, enrollment for this trial is currently open; it was initially listed on November 9th 2020 and last updated February 28th 2022. The research team seeks to recruit 55 patients at a single site."
Am I eligible to partake in this experiment?
"For eligibility in this clinical trial, applicants must suffer from a diagnosis of alcohol use disorder and be between 18-55. There is capacity for up to fifty-five participants."